Manchester: Explore new ways to pay for medicines

uk pharmaceutical industry has reached its only deal with the NHS in Manchester, saying it will change the way patients access medicines.a key part of the deal said it would allow Manchester's larger authorities to explore new ways of using the s1bn pharmaceutical budget based on patient outcomes.The British Pharmaceutical Industry Association, in partnership with the Greater Manchester Partnership for Health and Social Care, oversees the health and social care budget for the off-shelf areas, totalling ￡6 billion, and plans to improve drug use and safety, using NHS data.mike Thompson, president of the Pharmaceutical Industry Association of Great Britain, said:The industry recognises the challenges facing the NHS and we are committed to improving drug use to enhance the care and health of people in the region. By working with NHS England to improve the use and learning of real-time health data from hospitals and communities,has the best chance of producing the most appropriate and cost-effective drugs for patients in Greater Manchester and across the UK.Pharmaceutical Industry Association is one of the industry signatories to the new Letter of Intent (MoU) with Greater Manchester Health and Social Care Partners. It is side by side with the Ethical Medicines Industry Group (EMIG) and the British Association of General Manufacturers (BGMA).with Greater Manchester United and Health Innovation Manchester, they will create a Partnership Group for Greater Manchester and the Pharmaceutical Industry, led by Director Jon Rouse.s goal is to be the safest and most effective place in the world to receive drugs, and this unique step will help our pharmaceutical journey," he said. We want to improve people's health, get the best value for money from our drug budget, and continue to enhance Greater Manchester's global investment in research and development. The "" agreement is the first step; There are some important principles that we will observe and still have to be done, but it shows the strength of the partnership we are using in Greater Manchester. When we work together, we can really seize the opportunity. Theaims to improve the use and safety of medicines, using the big data and information capabilities provided by the NHS to identify, develop and deliver new drugs and treatments to patients.the team will also seek a successful Salford lung cancer study, a real-world trial sponsored by GlaxoSmithKline, in which representatives from 15 pharmaceutical companies demonstrated Real World data assessment capabilities in Greater Manchester on the afternoon of 24 February. (China Pharmaceutical 123 Network)